Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04945369

Follow-up During the Peripubertal Period of Preterm Children Included in the Protocol Entitled "EPIPOD".

Prematurity is associated with an increased risk of developing cardiovascular and metabolic disturbances in adulthood.

It has been demonstrated that the body composition of children born prematurely is different from that of children born under term with a deficit in fat free mass.

It can thus be wondered if this excessive adiposity does or does not predict the risk of insulin resistance in adulthood.

Children born prematurely, with a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol, and now aged between 8 and 14 years, will be included in the INFANTPOD protocol.

Analysis of body composition, insulin resistance, renal function, pulse wave velocity, eating behaviour and of physical activity will be performed.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

8 year–14 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children hospitalised at the Nantes University Hospital in the neonatal period
  • With a body composition measurement performed at discharge from neonatal hospitalization as part of the EPIPOD protocol
  • Born prematurely (under 35 weeks of amenorrhea)
  • Included in the Lift cohort with follow-up up to 7 years
  • Aged between 8 and 14 years at inclusion

Exclusion criteria

  • Children with an isolated metabolic disease: insulin-dependent diabetes; endocrine disease (Cushing's, hypothyroidism)
  • Age of 15 years or more
  • with a chromosomal anomaly
  • with contraindicating measurement of the BOP-POD: ventilatory support, continuous parenteral feeding, elimination stoma
  • Refusal of either parent or child

Treatment and study plan

clinical and biological measurements and questionnaires

Other

Blood and urinary samples collection for evaluation of insulin resistance and of renal function analysis.

Assessment of body composition by BOP-POD and by impedancemetry. Assessment of pulse wave by popmetre. Assessment of physical activity by accelerometer and by questionnaire Questionnaires for analysis of eating behaviour

Primary outcomes

  1. Insulin resistance as measured by the Triglyceride-Glucose Index

    Time frame: 1 day

Secondary outcomes

  1. Insulin resistance as measured by the Homeostasis Model Assessment - Insulin Resistance index

    Time frame: 1 day

  2. Body composition (percentage of fat versus fat free mass) by BOP-POD and by impedancemetry (biodyXpert) for assessment of body composition variations between peripubertal period and neonatal period

    Time frame: 1 day

  3. creatinine clearance

    Time frame: 1 day

  4. Eating behaviour using standardized questionnaire named Child Eating Behaviour questionnaire

    Time frame: 1 day

  5. Eating behaviour using standardized french questionnaire named "QCAJE Questionnaire Comportement Alimentaire du Jeune Enfant"

    Time frame: 1 day

Study contacts

Contact information is provided by the study sponsor or research team.

Anne FRONDAS, Doctor

CONTACT

[email protected]

+33 2 40 08 34 83

Sponsors and collaborators

Lead sponsor

Nantes University Hospital

Other

Registry information

Official study title

Follow-up During the Peripubertal Period of Preterm Children (Under 35 Weeks of Amenorrhea) Included in the "EPIPOD" Protocol : Evaluation of Insulin Resistance

Acronym: INFANTPOD

Important dates

Study start
2022
Primary completion
2028
Study completion
2028
First posted
Jun 30, 2021
Registry last updated
Nov 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.